<DOC>
	<DOCNO>NCT01403766</DOCNO>
	<brief_summary>Glomerular filtration rate ( GFR ) best know measurement kidney function . Serum creatinine ( blood test ) commonly use marker predict GFR . It convenient , inexpensive test involve single blood draw rapid result . However , creatinine several limitation blood level dependent age , body mass , sex . One gold standard measure GFR plasma clearance IV inject agent , iohexol . It find safe nontoxic prior study , practical clinical setting due need several time blood draw . Recent study investigate use cystatin C alternative marker predict GFR . Cystatin C also involve single blood draw , less confound factor creatinine since independent age , body mass , sex . Currently , remain controversial whether cystatin C significantly good biomarker estimate GFR creatinine . To date , large prospective cohort study compare cystatin C creatinine pediatric kidney transplant patient maintenance immunosuppression ( anti-rejection drug ) . Accurate measurement early detection deterioration GFR critical care patient population . The purpose study assess accuracy estimate GFR use cystatin C versus creatinine clearance equation compare surrogate gold standard iohexol GFR pediatric renal transplant patient .</brief_summary>
	<brief_title>Comparison Markers Kidney Function</brief_title>
	<detailed_description>Study patient come surveillance biopsy do standard care post-transplant . They make NPO midnight prior biopsy per routine . On arrival , standard care pre-biopsy blood draw along baseline study labs include serum enzymatic creatinine ( 1mL blood ) , cystatin C ( 1.5 mL blood ) , 1mL blood collect pre-iohexol infusion . Two IV 's start , one iohexol administration fluid , blood draw . Study patient start 1x maintenance intravenous fluid . The patient standard care protocol biopsy ultrasound suite . After biopsy 5 mL Iohexol ( Omnipaque 300 ) administer 1-2 minute , epinephrine , solumedrol , diphenhydramine hand event reaction although unlikely . The patient observe vital sign take 10 minute post-infusion . After biopsy , maintenance fluid continue completion study . Blood determination Iohexol level ( 1mL ) drawn 10 , 30 , 120 , 300 minute post iohexol infusion patient observe post biopsy . At completion study 300 minute post iohexol infusion , serum creatinine ( 1mL blood ) , cystatin C ( 1.5 mL blood ) drawn . The total volume blood drawn study 10mL . Creatinine ( enzymatic method ) determine Olympus system , Cystatin C ( Gentian assay ) determine AU400 Olympus System UCLA Department Pathology Laboratory Medicine Outreach Laboratory . Iohexol GFR determine University Rochester Medical Center Dr. Schwartz 's laboratory . Kidney biopsy grade updated Banff criterion , review blinded pathologist .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Cystatins</mesh_term>
	<criteria>Renal transplant patient age 1 &lt; 19 year old Stable allograft function ( history biopsy proven acute rejection increase creatinine &gt; 10 % baseline past 6 month ) No change maintenance immunosuppression month protocol biopsy Subject and/or parent must able understand provide inform consent Biopsy proven acute rejection past 6 month Change maintenance immunosuppression month protocol biopsy Known diabetes mellitus Known thyroid dysfunction Allergy Iohexol contrast medium Inability unwillingness participant legal guardian give write informed consent comply study protocol</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>pediatric</keyword>
	<keyword>kidney</keyword>
	<keyword>transplant</keyword>
	<keyword>GFR</keyword>
	<keyword>creatinine</keyword>
	<keyword>cystatin C</keyword>
	<keyword>iohexol</keyword>
</DOC>